A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| PKC ? , active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. |  |
| PKC-?, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| PKC?, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| PKCβ inhibitor 1 | PKC? inhibitor 1 is a potent, ATP-competitive, and selective PKC? inhibitor with IC50s of 21 and 5 nM for human PKC?1 and PKC?2, respectively. PKC? inhibitor 1 exhibits selectivity of more than 60-fold in favor of PKC?2 relative to other PKC isozymes (PKC?, PKC?, and PKC?)[1][2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 257879-35-9. Pack Sizes: 10 mM * 1 mL; 500 ?g; 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-13335. |  |
| PKC β pseudosubstrate | PKC β pseudosubstrate, a selective cell-permeable peptide inhibitor of protein kinase C (IC50 ~ 0.5 μM), consists of amino acids 19-31 of PKC pseudosubstrate domain linked by a disulphide bridge to a cell permeabilisation Antennapedia domain vector peptide. Synonyms: PKC beta pseudosubstrate; Protein kinase C beta pseudosubstrate; H-Cys(1)-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-OH.H-Cys(1)-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-OH; L-cysteinyl-L-arginyl-L-glutaminyl-L-isoleucyl-L-lysyl-L-isoleucyl-L-tryptophyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-arginyl-L-arginyl-L-methionyl-L-lysyl-L-tryptophyl-L-lysyl-L-lysine (1->1')-disulfide compound with L-cysteinyl-L-arginyl-L-phenylalanyl-L-alanyl-L-arginyl-L-lysyl-glycyl-L-alanyl-L-leucyl-L-arginyl-L-glutaminyl-L-lysyl-L-asparagyl-L-valine. Grade: >98%. CAS No. 172308-76-8. Molecular formula: C177H294N62O38S3. Mole weight: 3994.84. |  |
| PKC β pseudosubstrate | PKC β pseudosubstrate. Group: Biochemicals. Grades: Purified. CAS No. 172308-76-8. Pack Sizes: 1mg. US Biological Life Sciences. |  Worldwide |
| PKC?II/EGFR Inhibitor - CAS 145915-60-2 | The PKC?II/EGFR Inhibitor, also referenced under CAS 145915-60-2, controls the biological activity of PKC?II/EGFR. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKC?II Peptide Inhibitor I trifluoroacetate salt | ?95% (HPLC), lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| PKC? Inhibitor - CAS 257879-35-9 | The PKC? Inhibitor, also referenced under CAS 257879-35-9, controls the biological activity of PKC?. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKC Inhibitor, EGF-R Fragment 651-658, Myristoylated | The PKC Inhibitor, EGF-R Fragment 651-658, Myristoylated controls the biological activity of PKC. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKC Inhibitor Peptide 19-36 | The PKC Inhibitor Peptide 19-36 controls the biological activity of PKC. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKC/PKD-IN-1 | PKC/PKD-IN-1 (Compound 13C) is an orally active dual protein kinase C/D ( PKC/PKD ) inhibitor with an IC 50 value of 0.6 nM for PKD1. PKC/PKD-IN-1 can attenuate high-salt diet-induced cardiac hypertrophy and can be used in the study of heart failure [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1071135-06-2. Pack Sizes: 1 mg; 5 mg. Product ID: HY-128142. | |
| PKC?/? Pseudosubstrate Inhibitor | The PKC?/? Pseudosubstrate Inhibitor controls the biological activity of PKC?/?. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKC? Pseudosubstrate Inhibitor, Myristoylated | The PKC? Pseudosubstrate Inhibitor, Myristoylated controls the biological activity of PKC?. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKCTheta-IN-2 | PKCTheta-IN-2 (compound 14) is a potent and selective PKCθ inhibitor with an IC 50 of 0.25 nM. PKCTheta-IN-2 shows good selectivity over a wide range of kinases, including the PKC subfamily (30 kinases). PKCTheta-IN-2 inhibits the IL-2 production in a mouse ( IC 50 of 682 nM) [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1810742-60-9. Pack Sizes: 5 mg; 10 mg. Product ID: HY-164756. | |
| PKC? Translocation Inhibitor Peptide | The PKC? Translocation Inhibitor Peptide, Negative Control controls the biological activity of PKC?. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKC? Translocation Inhibitor Peptide, Negative Control | The PKC? Translocation Inhibitor Peptide, Negative Control controls the biological activity of PKC?. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKCζ-IN-1 | PKCζ-IN-1 is a compound that inhibits PKCζ and CDK2, showing an IC50 value of 5.18 nM for PKCζ and 1.04 μM for CDK2, with significant selectivity of 200-fold. PKCζ-IN-1 can reduce the activity of CDK2 while inhibiting PKC&zeta. Uses: Scientific research. Group: Signaling pathways. CAS No. 1132609-87-0. Pack Sizes: 1 mg; 5 mg. Product ID: HY-120497. | |
| PKC ζ pseudosubstrate | PKC ζ pseudosubstrate. Group: Biochemicals. Grades: Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| PKC ζ pseudosubstrate acetate | PKC ζ pseudosubstrate acetate, a synthetic peptide, is an inhibitor of protein kinase C (PKC) ζ that is attached to cell permeabilization Antennapedia domain vector peptide. It consists of amino acids 113-129 PKC ζ pseudosubstrate domains connected by a disulfide bridge to the cell permeabilization Antennapedia domain vector peptide. Synonyms: Protein kinase C zeta pseudosubstrate acetate; L-cysteinyl-L-seryl-L-isoleucyl-L-tyrosyl-L-arginyl-L-arginyl-glycyl-L-alanyl-L-arginyl-L-arginyl-L-tryptophyl-L-arginyl-L-lysyl-L-leucyl-L-tyrosyl-L-arginyl-L-alanyl-L-asparagine (1->1')-disulfide compound with L-cysteinyl-L-arginyl-L-glutaminyl-L-isoleucyl-L-lysyl-L-isoleucyl-L-tryptophyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-arginyl-L-arginyl-L-methionyl-L-lysyl-L-tryptophyl-L-lysyl-L-lysine; H-Cys-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu-Tyr-Arg-Ala-Asn-OH.H-Cys-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-OH (Disulfide bridge: Cys1-Cys1'). Grade: ≥95%. Molecular formula: C210H340N74O46S3. Mole weight: 4733.68. | |
| PKD2 Active human | recombinant, expressed in E. coli, ?70% (SDS-PAGE), aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| PKD-IN-1 dihydrochloride | PKD-IN-1 dihydrochloride (compound 32), an aminoethylamino-aryl (AEAA) compound, acts as PKD-1 inhibitor. PKD-IN-1 can be used for protein kinase D (PKD)-mediated diseases research [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2308510-39-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-131962A. | |
| PKD Inhibitor, CID755673 - CAS 521937-07-5 | The PKD Inhibitor, CID755673, also referenced under CAS 521937-07-5, controls the biological activity of PKD. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKF118-310 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PKG1alpha active human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PKG I? Inhibitor, Cell-Permeable | The PKG I? Inhibitor, Cell-Permeable controls the biological activity of PKG I?. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKG Inhibitor | The PKG Inhibitor controls the biological activity of PKG. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKG inhibitor peptide TFA | PKG inhibitor peptide TFA is an ATP-competitive inhibitor of cGMP-dependent protein kinase (PKG) with a Ki of 86 μM. It is an analog of a substrate peptide corresponding to a phosphorylation site of histone H2B, and inhibits phosphorylation of intact histones by PKA. Synonyms: H-Arg-Lys-Arg-Ala-Arg-Lys-Glu-OH.TFA; L-arginyl-L-lysyl-L-arginyl-L-alanyl-L-arginyl-L-lysyl-L-glutamic acid trifluoroacetic acid; cGMP Dependent Kinase Inhibitor Peptide TFA. Grade: ≥95%. Molecular formula: C40H75F3N18O12. Mole weight: 1057.13. | |
| PKG Substrate | PKG Substrate is a selective substrate for cGMP-dependent protein kinase (PKG). Synonyms: Arg-Lys-Arg-Ser-Arg-Ala-Glu; L-arginyl-L-lysyl-L-arginyl-L-seryl-L-arginyl-L-alanyl-L-glutamic acid; N5-(Diaminomethylidene)-L-ornithyl-L-lysyl-N5-(diaminomethylidene)-L-ornithyl-L-seryl-N5-(diaminomethylidene)-L-ornithyl-L-alanyl-L-glutamic acid; (S)-2-((6S,9S,12S,15S,18S,21S)-1,6-diamino-9-(4-aminobutyl)-12,18-bis(3-guanidinopropyl)-15-(hydroxymethyl)-1-imino-21-methyl-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosanamido)pentanedioic acid. Grade: ≥95%. CAS No. 81187-14-6. Molecular formula: C35H67N17O11. Mole weight: 902.01. | |
| PKG Substrate | PKG Substrate is a selective substrate for cGMP-dependent protein kinase ( PKG ). Uses: Scientific research. Group: Peptides. CAS No. 81187-14-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P1561. | |
| PKG Substrate acetate | PKG Substrate acetate is a selective substrate for cGMP-dependent protein kinase (PKG). Synonyms: H-Arg-Lys-Arg-Ser-Arg-Ala-Glu-OH.CH3CO2H; L-arginyl-L-lysyl-L-arginyl-L-seryl-L-arginyl-L-alanyl-L-glutamic acid acetic acid. Grade: ≥95%. Molecular formula: C37H71N17O13. Mole weight: 962.08. | |
| PKH 26 | PKH 26 is a red fluorescent dye, PKH 26 can stably bind to the lipid region of cell membrane and emit red fluorescence (Ex/Em=551/567 nm), which is mainly used for in vitro cell labeling, in vitro cell proliferation studies and in vivo and in vitro cell tracing studies[1]. Uses: Scientific research. Group: Fluorescent dye. CAS No. 154214-55-8. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-D1451. | |
| PKH 67 | PKH67 is a fluorescent cell binding dye with green fluorescence. PKH67 can stain the cell membrane and the Ex/Em is 490/502 nm. PKH67 is often used in combination with the non-specific red fluorescent dye PKH26 (Ex/Em=551/567 nm) to label cells, detect cell proliferation in vitro, and trace cells in vitro and in vivo[1][2]. Uses: Scientific research. Group: Fluorescent dye. CAS No. 257277-27-3. Pack Sizes: 100 ?L; 1 mL. Product ID: HY-D1421. | |
| PKI 14-22 amide,myristoylated | PKI 14-22 amide, myristoylated is a selective, cAMP-dependent, competitive PKA inhibitor with Ki=~36 nM. The myristoylation modification of PKI 14-22 amide, myristoylated makes it more permeable to cell membranes and blood-brain barriers than the precursor molecule. PKI 14-22 amide, myristoylated can block the phosphorylation of cAMP-dependent downstream targets (such as CREB). PKI 14-22 amide, myristoylated can prevent the development of morphine analgesic tolerance in mice, and also inhibits protein translation and negative-strand RNA synthesis of Zika virus. PKI 14-22 amide, myristoylated can be used in research fields such as opioid tolerance mechanisms and antiviral drugs[1][2][3]. Uses: Scientific research. Group: Peptides. CAS No. 201422-03-9. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P1291. | |
| PKI 14-22 amide, myristoylated | PKI 14-22 amide, myristoylated. Group: Biochemicals. Grades: Purified. CAS No. 201422-03-9. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| PKI 14-22 amide, myristoylated | PKI 14-22 amide, myristoylated is a cell-permeable version of protein kinase inhibitor PKI (14-22) amide. N-terminus is myristoylated to increase cell membrane permeability. The non-myristoylated version of this peptide is a highly specific inhibitor of cAMP-dependent protein kinase (PKA) with Ki=36 nM. This product is a useful tool for studying PKA in cellular systems. Synonyms: Protein kinase inhibitor-(14-22)-amide, myristoylated. Grade: >98%. CAS No. 201422-03-9. Molecular formula: C53H100N20O12. Mole weight: 1209.5. | |
| PKI-166 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PKI 166 hydrochloride | PKI 166 hydrochloride. Group: Biochemicals. Grades: Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| PKI (5-24) | PKI (5-24) is a competitive, non-reversible peptide inhibitor of PKA (cAMP-dependent protein kinase) (Ki = 2.3 nM). Its sequence is derived from the heat-stable skeletal muscle inhibitor protein of PKA. The PKA Inhibitor peptide binds to the catalytic subunit of PKA and displaces the regulatory subunit, and mimics protein substrate by binding to the catalytic site via the Arg-cluster basic residues. Synonyms: L-threonyl-L-threonyl-L-tyrosyl-L-alanyl-L-a-aspartyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-serylglycyl-L-arginyl-L-threonylglycyl-larginyl-L-aspartic acid; PKI (5-24); Protein Kinase A Inhibitor (5-24). CAS No. 99534-03-9. Molecular formula: C94H148N32O31. Mole weight: 2222.4. | |
| PKI (5-24) acetate | PKI (5-24) acetate is a competitive, non-reversible peptide inhibitor of PKA (cAMP-dependent protein kinase) (Ki = 2.3 nM). Synonyms: H-Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-His-Asp-OH.CH3CO2H; L-Threonyl-L-threonyl-L-tyrosyl-L-alanyl-L-α-aspartyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-serylglycyl-L-arginyl-L-threonylglycyl-L-arginyl-L-arginyl-L-asparaginyl-L-alanyl-L-isoleucyl-L-histidyl-L-aspartic acid acetate salt; PKI(5-24) acetate salt. Grade: ≥95%. Molecular formula: C96H152N32O33. Mole weight: 2282.43. | |
| PKLR Var1 active human | recombinant, expressed in E. coli, ?43% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PKLR Var2 active human | recombinant, expressed in E. coli, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PKM1 active human | recombinant, expressed in E. coli, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PKM2 Activator III (N- (4- (4- (2-Methoxyphenyl) piperazine-1-carbonyl) phenyl) quinoline-8-sulfonamide, Pyruvate Kinase M2 Activator III) | A cell-permeable quinoline-sulfonamide that acts as a potent allosteric PKM2 activator both in cell-free enzymatic assays (AC50 = 17nM with 40ng PKM2/200ul) and in cultures (AC50 = 45nM in A549 cells) via a high affinity, 2:1 stoichiometric binding, effectively locking PKM2 in an active tetrameric state resistant to known intracellular negative regulators of FBP-activated PKM2 tetramer. PKM2 stimulation by compound treatment is shown to result in decreased serine biosynthesis (by 56%; 500nM for 24h) with concomitant increase in serine influx as a compensating mechanism for maintaining cellular serine level necessary for supporting A549 proliferation. Simultaneous PKM2 activation and culture serine withdrawal results in cytostatic A549 growth arrest, but not apoptosis. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| PKM2-IN-1 | PKM2-IN-1 (compound 3k) is a pyruvate kinase M2 (PKM2) inhibitor with an IC50 of 2.95 ?M[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 94164-88-2. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-103617. | |
| PKN1/2-IN-1 | PKN1/2-IN-1 is a potent, cell penetrant and selective PKN2 (PRK2) inhibitor (IC50=16 nM; Ki=8 nM)[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 942425-34-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-145899. | |
| PKN2/PRK2, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| PKN3 active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| PknG Inhibitor - CAS 329221-38-7 | The PknG Inhibitor, also referenced under CAS 329221-38-7, controls the biological activity of PknG. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKR activator 3 | PKR activator 3 is a pyruvate kinase isoform PKR activator extracted from patent WO2014139144A1, compound 160. PKR activator 3 can be used for the research of PKR function related diseases, including cancer, diabetes, obesity, autoimmune disorders, and benign prostatic hyperplasia [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1628428-01-2. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-19702. | |
| PKR-IN-C16 | PKR-IN-C16 (Compound C16) is a specific double-stranded RNA-dependent protein kinase (PKR) inhibitor. PKR-IN-C16 shows promising neuroprotective properties and can rescue acute brain lesions[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 608512-97-6. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13977A. | |
| PKR Inhibitor - CAS 608512-97-6 | The PKR Inhibitor, also referenced under CAS 608512-97-6, controls the biological activity of PKR. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKR Inhibitor III, 7DG (Double-stranded RNA-activated Protein Kinase Inhibitor III, EIF2AK2 Inhibitor III, 7-Desacetoxy-6,7-dehydrogedunin, Double-stranded RNA-dependent Protein Kinase Inhibitor III) | A cell-permeable gedunin analog that directly targets PKR via reversible interaction inhibits PKR-mediated cellular events by disrupting PKR signaling complexes assembly, such as IkK complex and inflammasome / pyroptosome, resulting in effective blockage of LPS-induced IkBbeta degradaion (20uM) and protection against anthrax toxin LT-induced caspase-1 activation as well as subsequent pyroptosis (10uM) in murine macrophage J774 cultures. PKR is also known to mediate LT-induced apoptosis via its kinase activity in LPS-primed Macrophages derived from C57BL/6 with a resistent NLRP1 allele, inhibitable by C16, but not by 7DG, while LT-induced pyroptosis in J774 cultures is insensitive to C16 treatment. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 5mg. Molecular Formula: C??H??O?. US Biological Life Sciences. | Worldwide |
| PKR Inhibitor, Negative Control - CAS 852547-30-9 | The PKR Inhibitor, Negative Control, also referenced under CAS 852547-30-9, controls the biological activity of PKR. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| PKSI-527 | PKSI-527 is a new, highly selective plasma kallikrein inhibitor. PKSI-527 can suppress collagen-induced arthritis (CIA) by modifying the kallikrein-kinin system [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 128837-71-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-123133. | |
| PK-THPP | PK-THPP. Group: Biochemicals. Grades: Purified. CAS No. 1332454-07-5. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| PK-THPP | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PKUMDL-WQ-2101 | PKUMDL-WQ-2101 is a non-NAD+-competing allosteric phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 34.8 ?M. PKUMDL-WQ-2101 exhibits antitumor activity[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 304481-72-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-123269. | |
| PKUMDL-WQ-2101 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PKUMDL-WQ-2201 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PL 017 | PL 017. Group: Biochemicals. Grades: Purified. CAS No. 83397-56-2. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| PL-101 | PL-101 is an antibacterial peptide isolated from Styela plicata. Grade: >96%. | |
| PL405 trifluoroacetate salt | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PL415 trifluoroacetate salt hydrate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PLA2G12A from Human, Recombinant | Human PLA2G12A (GenBank Accession No. NM_030821), amino acids 23-189 (end) with C-terminal His-tag, MW=22 kDa, expressed in a mammalian cell expression system. Human pla2g12a (genbank accession no. nm_030821), amino acids 23-189 (end) with c-terminal his-tag, mw=22 kda, expressed in a mammalian cell expression system. Applications: Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. Group: Enzymes. Synonyms: PLA2G12A; phospholipase A2; GXII; Phospholipase A2 G12; ROSSY; PLA2G12. Purity: > 80% (SDS-PAGE). PLA2. Mole weight: mol wt 22 kDa. Storage: -20°C. Form: aqueous solution; Fomulated in 40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 200 mM Imidazole, and 20% Glycerol. Source: Mammalian cells. Species: Human. PLA2G12A; phospholipase A2; GXII; Phospholipase A2 G12; ROSSY; PLA2G12. Cat No: NATE-0589. |  |
| PLA2G12A human | recombinant, expressed in mammalian cells, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PLA2G12B from Human, Recombinant | Human PLA2G12B (GenBank Accession No. NM_032562), amino acids 20-295 (end) with C-terminal His tag, MW=21.1 kDa, expressed in a mammalian cell expression system. Human pla2g12b (genbank accession no. nm_032562), amino acids 20-295 (end) with c-terminal his tag, mw=21.1 kda, expressed in a mammalian cell expression system. Applications: Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. Group: Enzymes. Synonyms: PLA2G12B; phospholipase A2; FKSG71; GXIIB; Phospholipase A2 G12. Purity: > 60% (SDS-PAGE). PLA2. Mole weight: mol wt 21.1 kDa. Storage: -70°C. Form: aqueous solution; Fomulated in 40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 200 mM Imidazole, and 20% Glycerol. Source: Mammalian cells. Species: Human. PLA2G12B; phospholipase A2; FKSG71; GXIIB; Phospholipase A2 G12. Cat No: NATE-0590. | |
| PLA2G12B human | recombinant, expressed in mammalian cells, ?60% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PLA 3D printing filament | PLA 3D printing filament. Group: 3d printing materials. CAS No. 9051-89-2. |  |
| PLA-b-PPEEA | Polylactic acid (PLA) is a kind of non-toxic,non irritating synthetic polymer material with excellent biodegradability,compatibility and absorbability.It can be used as drug transport material and tissue engineering scaffold material. Synonyms: polylactic acid-b-PPEEA. Product ID: MSMN-062. Category: Raw Materials. |  |
Our database is helping our users find suppliers everyday.
